Siemens Healthineers AG
General ticker "SEMHF" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $61.7B (TTM average)
Siemens Healthineers AG follows the US Stock Market performance with the rate: 4.3%.
Estimated limits based on current volatility of 2.1%: low 43.23$, high 45.08$
Factors to consider:
- Company pays dividends (annually): last record date 2026-02-09, amount 1.18$ (Y2.68%)
- Earnings for 3 months up through Q1 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-09-30 to 2027-09-30
- 2025-09-30 to 2026-09-30 estimated range: [46.48$, 67.01$]
- 2026-09-30 to 2027-09-30 estimated range: [49.65$, 71.08$]
Financial Metrics affecting the SEMHF estimates:
- Negative: with PPE of 25.6 at the end of fiscal year the price was high
- Positive: 7.67 < Operating profit margin, % of 14.69
- Positive: 19.40 < Shareholder equity ratio, % of 40.66 <= 42.68
- Positive: Industry inventory ratio change (median), % of -0.45 <= -0.16
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 4.00
- Positive: 0.01 < Operating cash flow per share per price, % of 5.90
- Negative: Investing cash flow per share per price, % of -1.74 <= -0.63
Short-term SEMHF quotes
Long-term SEMHF plot with estimates
Financial data
| YTD | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|
| Operating Revenue | €21,680.00MM | €22,363.00MM | €23,419.00MM |
| Operating Expenses | €19,240.00MM | €19,063.00MM | €19,978.00MM |
| Operating Income | €2,440.00MM | €3,300.00MM | €3,441.00MM |
| Non-Operating Income | €-512.00MM | €-777.00MM | €-583.00MM |
| Interest Expense | €296.00MM | €476.00MM | €425.80MM |
| R&D Expense | €1,866.00MM | €1,918.00MM | €1,962.00MM |
| Income(Loss) | €1,928.00MM | €2,523.00MM | €2,858.00MM |
| Taxes | €403.00MM | €564.00MM | €686.28MM |
| Profit(Loss)* | €1,509.00MM | €1,942.00MM | €2,148.00MM |
| Stockholders Equity | €18,081.00MM | €18,199.00MM | €21,168.86MM |
| Inventory | €4,294.00MM | €4,179.00MM | €4,086.00MM |
| Assets | €46,684.00MM | €46,055.00MM | €52,065.53MM |
| Operating Cash Flow | €1,809.00MM | €2,469.00MM | €3,089.00MM |
| Capital expenditure | €838.00MM | €696.00MM | €820.00MM |
| Investing Cash Flow | €-1,069.00MM | €-666.00MM | €-908.00MM |
| Financing Cash Flow | €-380.00MM | €-1,300.00MM | €-2,594.00MM |
| Earnings Per Share** | €1.35 | €1.74 | €1.92 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.